Frontiers in Lupus

Original Research

Published on 12 Sep 2024

Comparative efficacy and safety of belimumab and hydroxychloroquine in the maintenance phase in patients with systemic lupus erythematosus: a retrospective cohort study

Koichi Kimura
Masahiro Ayano
Shun-Ichiro Ota
Kazuo Kushimoto
Yasutaka Kimoto
Hiroki Mitoma
Nobuyuki Ono
Yojiro Arinobu
Koichi Akashi
Takahiko Horiuchi

Frontiers in Lupus

doi 10.3389/flupu.2024.1459949

1,577 views

Perspective

Published on 05 Sep 2024

Enhancing systemic lupus erythematosus care and outcomes through innovative interventions by the rheumatology initiative (tRi) in Ghana

Dzifa Dey
Rosetta Bobade
Bright Katso
Saudatu Issaka
Angela Charis
Abdul Aziz Can Tamakloe
Padiki Narh

Frontiers in Lupus

doi 10.3389/flupu.2024.1462320

939 views

Perspective

Published on 02 Sep 2024

Strengthening lupus education and coordinated care in developing countries

Sandra V. Navarra

Frontiers in Lupus

doi 10.3389/flupu.2024.1462111

1,068 views

Mini Review

Published on 21 Aug 2024

Disease activity assessment in systemic lupus erythematosus

Angela Lin
Ambika Wakhlu
Kathryn Connelly

Frontiers in Lupus

doi 10.3389/flupu.2024.1442013

2,926 views

Case Report

Published on 21 Aug 2024

Case Report: Overlap syndrome of relapsing polychondritis and systemic lupus erythematosus observed in women: a comprehensive review and unique case presentation

Antonio Bustos-Merlo
Nuria Navarrete-Navarrete
Lourdes González-Navarrete
María Martín-Armada

Frontiers in Lupus

doi 10.3389/flupu.2024.1334214

720 views

Editorial

Published on 20 Aug 2024

Editorial: New insights into interferons and proinflammatory cytokines in lupus

Wendy I. White
Jillian M. Richmond
Antonios Psarras

Frontiers in Lupus

doi 10.3389/flupu.2024.1465771

545 views
1 citation

Editorial

Published on 17 Jun 2024

Editorial: Advancements and challenges in epidemiology of lupus

Noa Schwartz
Anca D. Askanase

Frontiers in Lupus

doi 10.3389/flupu.2024.1439486

861 views

Correction

Published on 04 Jun 2024

Corrigendum: Microfibrillar-associated protein 4 interaction with inflammation and clinical characteristics in neuropsychiatric systemic lupus erythematosus

Maria Alexandra Bandehkhoda Wegener
Sören Möller
Mads Nikolaj Olesen
Jonna Skov Madsen
Grith Lykke Sorensen
Anne Voss
Nasrin Asgari

Frontiers in Lupus

doi 10.3389/flupu.2024.1432884

479 views

Original Research

Published on 30 May 2024

Insights into maternal and neonatal anti-Ro/SSA antibodies: implications on pregnancy and neonatal health

Samar Al Emadi
Eman Satti
Nawal Hadwan

Frontiers in Lupus

doi 10.3389/flupu.2024.1358121

2,042 views

Review

Published on 24 May 2024

The 330 risk loci known for systemic lupus erythematosus (SLE): a review

Viktoryia Laurynenka
John B. Harley

Frontiers in Lupus

doi 10.3389/flupu.2024.1398035

3,584 views
1 citation

Original Research

Published on 14 May 2024

Microfibrillar-associated protein 4 interaction with inflammation and clinical characteristics in neuropsychiatric systemic lupus erythematosus

Maria Alexandra Bandehkhoda Wegener
Sören Möller
Mads Nikolaj Olesen
Jonna Skov Madsen
Grith Lykke Sorensen
Anne Voss
Nasrin Asgari

Frontiers in Lupus

doi 10.3389/flupu.2024.1386256

877 views

Original Research

Published on 04 Apr 2024

Preterm birth, preeclampsia, gestational hypertension and offspring birth weight in women with active juvenile idiopathic arthritis and healthy controls

Carina Götestam Skorpen
Stian Lydersen
Kjell Å. Salvesen
Marianne Wallenius

Frontiers in Lupus

doi 10.3389/flupu.2024.1375857

951 views
1 citation

Original Research

Published on 26 Mar 2024

Serum isolevuglandin IgG antibody concentrations are increased in patients with systemic lupus erythematosus and associated with lower 24-hour blood pressure

Anastasiia Phothisane
Annette M. Oeser
Shahensha Shaik
Qiong Wu
Olivia Posey
Sean S. Davies
Jaya Krishnan
David M. Patrick
C. Michael Stein
Michelle J. Ormseth

Frontiers in Lupus

doi 10.3389/flupu.2024.1377164

796 views

Original Research

Published on 21 Mar 2024

Development of The Lupus Clinical Trials Enrollment Decision Aid: a pilot study

Leila Khalili
Rita Kukafka
Julia Weiner
Sean Inzerillo
Wei Tang
Laura Geraldino-Pardilla
Nancyanne Schmidt
Yevgeniyia Gartshteyn
Kathleen Alvarez
Anca Askanase

Frontiers in Lupus

doi 10.3389/flupu.2024.1373534

1,088 views

Original Research

Published on 19 Mar 2024

A critical role for IFN-β signaling for IFN-κ induction in keratinocytes

Bin Xu
Jon Musai
Yee Sun Tan
Grace A. Hile
William R. Swindell
Benjamin Klein
J. Tingting Qin
Mrinal K. Sarkar
Johann E. Gudjonsson
J. Michelle Kahlenberg

Frontiers in Lupus

doi 10.3389/flupu.2024.1359714

2,615 views
4 citations

Review

Published on 06 Feb 2024

Insights into future management of lupus nephritis

Anca D. Askanase
Maria Dall’Era
Salem Almaani

Frontiers in Lupus

doi 10.3389/flupu.2024.1334932

4,584 views
1 citation

39 Publications

Volume 2 - 2024

Comparative efficacy and safety of belimumab and hydroxychloroquine in the maintenance phase in patients with systemic lupus erythematosus: a retrospective cohort study

Enhancing systemic lupus erythematosus care and outcomes through innovative interventions by the rheumatology initiative (tRi) in Ghana

Strengthening lupus education and coordinated care in developing countries

Disease activity assessment in systemic lupus erythematosus

Case Report: Overlap syndrome of relapsing polychondritis and systemic lupus erythematosus observed in women: a comprehensive review and unique case presentation

Editorial: New insights into interferons and proinflammatory cytokines in lupus

Editorial: Advancements and challenges in epidemiology of lupus

Corrigendum: Microfibrillar-associated protein 4 interaction with inflammation and clinical characteristics in neuropsychiatric systemic lupus erythematosus

Insights into maternal and neonatal anti-Ro/SSA antibodies: implications on pregnancy and neonatal health

The 330 risk loci known for systemic lupus erythematosus (SLE): a review

Microfibrillar-associated protein 4 interaction with inflammation and clinical characteristics in neuropsychiatric systemic lupus erythematosus

Preterm birth, preeclampsia, gestational hypertension and offspring birth weight in women with active juvenile idiopathic arthritis and healthy controls

Serum isolevuglandin IgG antibody concentrations are increased in patients with systemic lupus erythematosus and associated with lower 24-hour blood pressure

Development of The Lupus Clinical Trials Enrollment Decision Aid: a pilot study

A critical role for IFN-β signaling for IFN-κ induction in keratinocytes

Insights into future management of lupus nephritis